<p>* Infants with a follow up <28 days were excluded.</p><p>**Adjusted for maternal age, gender, and preterm birth n = 446</p><p>§ Analysis restricted to period 1996–2006</p><p>Data censored at 1 year of age. All p-values are from Wald tests.</p><p>cARV = combined antiretroviral ZDV = zidovudine 3TC = lamivudine</p><p>Hazard Ratios of Severe Infection Occuring Between 29 and 364 Days of Age According to Baseline Characteristics (N = 519<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0135375#t003fn001" target="_blank">*</a></sup>, 52 Infants with Severe Infections).</p
Concerns have been raised over possible adverse effects of prophylactic antiretroviral therapy (ART)...
<p>Note: there were no infants with underlying BPD at gestational age 33–36 months. BPD, bronchopulm...
<p>Survival among infants with postnatal CMV infection (negative CMV PCR at birth, positive CMV PCR ...
<p>* Infants with a follow up <28 days were excluded.</p><p>** Adjusted for CD4 and preterm birth n ...
<p>Occurrence of severe infections during the first year of life according to period of birth & expo...
<p>The maximum grade adverse event within each laboratory test (hemoglobin, Hgb; absolute neutrophil...
<p>The proportion of infants having an adverse event of the specified grade is determined using each...
To investigate the outcome in children perinatally infected with HIV-1 whose mothers received zidovu...
BACKGROUND: Mathematical modeling has provided important insights into HIV infection dynamics in adu...
Six weeks of zidovudine (ZDV) is recommended for postnatal prophylaxis of HIV-exposed infants, but c...
OBJECTIVE: To investigate the outcome in children perinatally infected with HIV-1 whose mothers rece...
While it would have been possible to include regions other than EA in S1 Fig, we opted not to becaus...
<p>Red and blue lines indicate infected and uninfected infants, respectively. Calculations were base...
Objective: To investigate the outcome in children perinatally infected with HIV-1 whose mothers rece...
<p>BPD, bronchopulmonary dysplasia.</p><p>N = total premature babies (by gestational age); n = R...
Concerns have been raised over possible adverse effects of prophylactic antiretroviral therapy (ART)...
<p>Note: there were no infants with underlying BPD at gestational age 33–36 months. BPD, bronchopulm...
<p>Survival among infants with postnatal CMV infection (negative CMV PCR at birth, positive CMV PCR ...
<p>* Infants with a follow up <28 days were excluded.</p><p>** Adjusted for CD4 and preterm birth n ...
<p>Occurrence of severe infections during the first year of life according to period of birth & expo...
<p>The maximum grade adverse event within each laboratory test (hemoglobin, Hgb; absolute neutrophil...
<p>The proportion of infants having an adverse event of the specified grade is determined using each...
To investigate the outcome in children perinatally infected with HIV-1 whose mothers received zidovu...
BACKGROUND: Mathematical modeling has provided important insights into HIV infection dynamics in adu...
Six weeks of zidovudine (ZDV) is recommended for postnatal prophylaxis of HIV-exposed infants, but c...
OBJECTIVE: To investigate the outcome in children perinatally infected with HIV-1 whose mothers rece...
While it would have been possible to include regions other than EA in S1 Fig, we opted not to becaus...
<p>Red and blue lines indicate infected and uninfected infants, respectively. Calculations were base...
Objective: To investigate the outcome in children perinatally infected with HIV-1 whose mothers rece...
<p>BPD, bronchopulmonary dysplasia.</p><p>N = total premature babies (by gestational age); n = R...
Concerns have been raised over possible adverse effects of prophylactic antiretroviral therapy (ART)...
<p>Note: there were no infants with underlying BPD at gestational age 33–36 months. BPD, bronchopulm...
<p>Survival among infants with postnatal CMV infection (negative CMV PCR at birth, positive CMV PCR ...